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Introduction
Micro-organisms are the richest source of novel bioac-
tive compounds. Historically, most bioactive microbial
products have been obtained from two taxonomic
groups (actinomycetes and filamentous fungi) and
mainly from terrestrial habitats. In recent decades, the
diffusion of bacterial resistance to antibiotics has stimu-
lated the exploration of new environments and the
screening of less exploited microbial groups endowed
with a more versatile secondary metabolism such as
myxobacteria (Gaspari et al. 2005) and cyanobacteria
(Burja et al. 2001). To achieve this, the development of
specific isolation and cultivation methods and the
opportunity to access geographically diverse sampling
areas and different ecological niches are of fundamental
importance. In this context, a joint academic and indus-
trial research project [MICROMAT EU Project BIO4-98-
0040 (http://www.nerc-bas.ac.uk/public/mlsd/micromat)]
was carried out aimed at the characterization and
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Aims: To exploit the cyanobacterial diversity of microbial mats growing in the
benthic environment of Antarctic lakes for the discovery of novel antibiotic
and antitumour activities.
Methods and results: In all, 51 Antarctic cyanobacteria isolated from benthic
mats were cultivated in the laboratory by optimizing temperature, irradiance
and mixing. Productivity was generally very low (£60 mg l)1 d)1) with growth
rates (l) in the range of 0Æ02–0Æ44 d)1. Growth rates were limited by photosen-
sitivity, sensitivity to air bubbling, polysaccharide production or cell aggrega-
tion. Despite this, 126 extracts were prepared from 48 strains and screened for
antimicrobial and cytotoxic activities. Seventeen cyanobacteria showed antimi-
crobial activity (against the Gram-positive Staphylococcus aureus, the filamen-
tous fungus Aspergillus fumigatus or the yeast Cryptococcus neoformans), and 25
were cytotoxic. The bioactivities were not in accordance with the phylogenetic
grouping, but rather strain-specific. One active strain was cultivated in a 10-l
photobioreactor.
Conclusions: Isolation and mass cultivation of Antarctic cyanobacteria and LC-
MS (liquid chromatography ⁄mass spectrometry) fractionation of extracts from
a subset of those strains (hits) that exhibited relatively potent antibacterial
and ⁄or antifungal activities, evidenced a chemical novelty worthy of further
investigation.
Significance and impact of the study: Development of isolation, cultivation
and screening methods for Antarctic cyanobacteria has led to the discovery of
strains endowed with interesting antimicrobial and antitumour activities.
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biotechnological exploitation of the metabolic diversity
of bacteria and fungi living in microbial mats at the
bottom of Antarctic lakes (Tindall et al. 2000; Brambilla
et al. 2001; Van Trappen et al. 2002; Taton et al. 2003,
2006a,b; Marinelli et al. 2004). Antarctica is the coldest
and windiest continent; it is remote, hostile and unin-
habited and it offers, as well as its surrounding seas, a
unique opportunity to investigate and exploit the bio-
diversity of unexplored microbial communities (Tindall
2004). The extreme climate of Antarctica has favoured
the evolution of indigenous species and novel biochemi-
cal adaptations. The Antarctic benthic mats, which have
accumulated for thousands of years virtually undis-
turbed, due to the extreme climatic conditions and the
absence of higher metazoans, are dominated by cyano-
bacteria, including many taxa that have never been iso-
lated and ⁄or cultivated before. In these dense microbial
communities, the production of antibiotics and toxins
may confer a competitive survival advantage (Wiegand
and Pflugmacher 2005). Although the search for bioac-
tive products (i.e. antitumour, antifungal, antibacterial
and antiviral molecules) from cyanobacteria has intensi-
fied during the last few decades (Burja et al. 2001,
2003), to our knowledge, this is the first report on mass
cultivation and pharmaceutical screening of a significant
number of Antarctic cyanobacteria. The work aimed at
an industrially oriented characterization of the isolated
cyanobacteria by testing their bioactivities with the vali-
dated protocols of a pharmaceutical company, and by
evaluating their growth capacity in order to select strains
which, besides interesting bioactivities, were endowed of
a good mass cultivation potential, necessary to produce
high amounts of bioactive biomass.
Materials and methods
Strain isolation and characterization
Fifty-nine cyanobacterial strains were isolated from 27
benthic microbial mat samples (Fig. 1) collected during
the Antarctic summers 1997–1998 and 1998–1999 from
23 lakes and ponds in the Larsemann Hills, Bølingen
Islands, Vestfold Hills, Rauer Islands and the McMurdo
Dry Valleys. Isolation methods and morphological-
molecular characterization of these strains have been
described in detail elsewhere (Taton et al. 2006b). From
the molecular analysis, several OTUs (Operational Taxo-
nomic Unit) were defined as groups of partial 16S
rRNA gene sequences that exhibit more than 97Æ5%
similarity, using the Escherichia coli positions 405–780,
not taking into account indels and ambiguous bases
(Stackebrandt and Goebel 1994; Taton et al. 2003,
2006a).
Mass cultivation
Fifty-one out of the 59 isolates were mass cultivated in
the laboratory to obtain sufficient biomass for bioactivity
screenings. The remaining eight strains grew too slowly to
allow mass cultivation during this project. The 51 strains
were cultivated in batch under sterile conditions in 500–
1100 ml glass tubes bubbled with air ⁄CO2 (98 ⁄ 2, v ⁄ v) or
in 1000 ml Erlenmeyer flasks (400 ml culture volume)
kept in an orbital shaker flushed with air ⁄CO2 (95 ⁄ 5,
v ⁄ v). Continuous light was provided by daylight fluores-
cent tubes (Osram Lumilux L 58W) and its intensity ran-
ged from 10 to 30 lmol photons m)2 s)1, except for few
strains which were cultivated at about 90 lmol photons
m)2 s)1. PAR (Photosynthetic Active Radiation) irradi-
ance was measured using an Li185A quantum meter
equipped with an Li190SB cosine quantum sensor
(Li-Cor, Lincoln, NE, USA). Temperature was maintained
at 20 ± 2C for all the cultures. Freshwater cyanobacteria
were cultivated in BG11 (Rippka et al. 1979) or BG11
without NO3
) (BG110), added with NaHCO3 (0Æ5%) as a
Figure 1 Mat from a lake in the Larsemann Hills showing a finely
laminated structure that has accumulated over several thousand years.
Microbial mats were collected using a gravity corer with a clear plastic
core tube. Samples for cyanobacteria isolation, mass cultivation and
screening were taken from the living surface layer of the mat.
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buffer. ASNIII (Waterbury and Stanier 1981) at half con-
centration was used for strains isolated from saline lakes.
Bacterial contamination of the cultures was evaluated by
observation using an optical microscope. Biomass was
harvested at the end of the linear growth phase by filtra-
tion on a nylon net and carefully washed with saline solu-
tion (1 g l)1 for cultures in BG11 and 4 g l)1 for those in
half strength ASNIII) under vacuum. Contamination was
very low and was significantly reduced after the washing.
When high amounts of polysaccharide were produced,
harvesting was carried out by centrifugation. Part of the
harvested biomass was dried in a stove at 100C to con-
stant weight in order to determine its water content and
calculate the productivity (mg l)1 d)1) on the basis of the
dry weight. The productivity was calculated as the bio-
mass concentration increase from inoculum to harvesting
time (end of the linear growth phase). At 20–22C, three
strains did not grow; for 15 strains it was possible to
perform only one batch. From three to six batches were
carried out for 16 strains and 8–12 batches for the
remaining 17 strains. The productivity was calculated as
the mean of the productivities obtained in the different
batches. The coefficient of variation was used to evaluate
the variability in productivity.
In order to obtain a larger amount of biomass and fur-
ther characterize the active molecule of one of the
selected hits (ANT.L52.6), the cyanobacterium was mass
cultivated in a 10-l photobioreactor constituted by a glass
cylinder of 10 cm diameter and 1Æ5 m height, illuminated
by daylight fluorescent tubes (at about 30 lmol photons
m)2 s)1). The culture was bubbled with an air ⁄CO2 mix-
ture (98 ⁄ 2, v ⁄ v) provided through a gas diffuser placed at
the bottom of the reactor. Temperature was kept at 18–
20C. The culture was carried out in semi-continuous
conditions for 88 days with a harvest rate of 40–50%
every 2 weeks.
Extract preparation
Five different extraction protocols were set up on the
basis of biomass availability, but also considering techni-
cal drawbacks and indications obtained from the preli-
minary results with the extracts already processed
(Table 1). Ethyl acetate extraction (48 strains) was always
performed and it was preferred to methanol extraction
(36 strains), as the resulting extract was less turbid and
required less manipulation before the bioactivity tests. For
the last group of 13 strains (see Table 1), thawing water
(already obtained from 35 strains) was not produced and
biomass was lyophilized.
To prepare the extracts, 1 g of biomass (dry weight)
was extracted in 50 ml of solvent overnight. The suspen-
sion was then filtered on paper and the solvent evapo-
rated under vacuum. When thawing water was obtained
from frozen material, the water derived from 1 g of bio-
mass (dry weight) was frozen again, lyophilised and
extracted with 50 ml of methanol (Biondi et al. 2004).
Finally, all the dry residues were re-dissolved in
DMSO : H2O 1 : 9 (v ⁄ v) in a proportion of 2 ml per
gram of biomass extracted. When £0Æ5 g of biomass were
extracted a proportion of 5 ml g)1 was used.
Screening for antimicrobial activities
Procedures used for the antimicrobial screening by mi-
crotiter assay in liquid have been previously described
(Gaspari et al. 2005). The following human pathogens
were used as target organisms: Staphylococcus aureus




extracted Biomass treatment Scheme of the extraction
1 14 Frozen, then thawed obtaining thawing
water and thawed biomass
1 g biomass in ethylacetate
1 g biomass in methanol
Lyophilised thawing water from 2 g of biomass in methanol
2 11 As in method 1 1 g biomass in ethylacetate
Lyophilised thawing water from 1 g of biomass in methanol
3 7 As in method 1 0Æ5 g biomass in ethylacetate
Successively, the same biomass in methanol
Lyophilised thawing water from 0Æ5 g biomass in methanol
4 4 As in method 1 2 g biomass in methanol
Successively, the same biomass in ethylacetate
Lyophilised thawing water from 2 g biomass in methanol
1 g biomass in ethylacetate
5 13 Lyophilised 0Æ2 to 0Æ8 g biomass in ethylacetate
Successively, the same biomass in methanol
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ATCC 6538 and Aspergillus fumigatus ATCC 90112 from
the American Type Culture Collection; E. coli L 47 and
Candida albicans L 145 from the Lepetit Culture Collec-
tion c ⁄o Vicuron Pharmaceuticals, Gerenzano, Varese,
Italy; Cryptococcus neoformans IUM 94698 from the
collection of the Istituto di Igiene, Universita` di Milano,
Italy. Staph. aureus and E. coli were cultivated in cation-
adjusted Mueller Hinton broth (CAMHB, Difco) and C.
albicans, A. fumigatus and C. neoformans in antibiotic
medium no. 3 + 2% glucose (AM3, Difco). 1 · 104 CFU
or conidia ml)1 of each strain were inoculated into 90 ll
of appropriate culture broth added to 40 ll of the cyano-
bacterial extract to be screened. Incubation time was
18–24 h, except for C. neoformans and A. fumigatus
(48 h). Incubation was carried out under aerobic condi-
tions at 35C, except for A. fumigatus (30C). Optical
density at 620 nm was measured to detect pathogen
growth inhibition. One point test was used to select the
‘active’ strains, i.e. those inhibiting more than 80% of the
pathogen growth in comparison with the control (set as
100%) when only DMSO ⁄H2O was added to the patho-
gen inoculum. The broth micro-dilution method was
used to confirm positive broths and to assay their potency
(Gaspari et al. 2005). The activity is expressed as grams of
extracted biomass (dry weight) necessary to inhibit the
growth of the target organism in 1 l of inoculated
medium of at least 80% compared to the control (Biondi
et al. 2004).
Cytotoxic assay
Human cervix epitheloid carcinoma cells (HeLa cells),
obtained from the Istituto Zooprofilattico di Brescia,
Italy, were continuously cultured in a complete medium
(RPMI 1640 supplemented with 10% foetal calf serum,
Penicillin 100 units ml)1 and Streptomycin 100 lg ml)1)
at 37C and 5% CO2 and split at confluence using tryp-
sin. Cells for testing were seeded in microtiter plates at
a density of 105 cells per well. 90 ll of complete med-
ium plus 10 ll of the cyanobacterial extract or control
DMSO ⁄H2O solutions were added. Plates were incubated
at 37C and 5% CO2 for 24 h. The cells were then
washed with 200 ll per well of a phosphate buffer solu-
tion at pH 7Æ3 and pulsed for 4 h with 3H-thymidine
0Æ1 lCi (Amersham TRK61) in 100 ll per well of
complete medium without serum. Cells were trypsinized
and harvested on a glass fibre filter with a semi-auto-
mated cell harvester (Wallac, Gaithersburg, MD, USA).
The incorporated radioactivity was measured using a
Betaplate scintillation counter (Wallac). Those samples
able to inhibit 40% cell thymidine uptake relative to
the control were flagged as cytotoxic. The broth micro-
dilution method was used to confirm positive broths
and to assay their potency (Marinelli et al. 2004; Gaspari
et al. 2005).
The activity is expressed as the concentration of
extracted biomass (dry weight) necessary to inhibit 40%
cell thymidine uptake relative to the control.
Liquid chromatography and mass spectrometry of active
fractions
Extracts were fractionated by high performance liquid
chromatography (HPLC) using a Waters Chromatograph
(Milford, MA, USA) on a Waters Simmetry-shield C18,
5 lm (250 · 4Æ6 mm) eluted at 1 ml min)1 flow rate at
room temperature. Elution followed a linear gradient from
9% to 85% of phase B in 28 min and isocratic at 85% for
the last 4 min. Phase A was acetonitrile: 20 mM ammo-
nium formate buffer pH = 4Æ5, 5 : 95 v ⁄ v, and phase B was
acetonitrile (HPLC grade). Detection was performed by a
photodiode array from 220 to 600 nm and by mass spec-
trometer. The eluent from the column was split in a ratio
10 : 90 and the larger amount (about 900 ll min)1) was
diverted to an ultraviolet detector and then collected in a
microtiter support for further assays (1 min collection for
each testing tube: 32 tubes). The remaining 100 ll min)1
were diverted to the ESI interface of the ion trap mass spec-
trometer (ThermoQuest, Finningan MAT, San Jose, CA,
USA). Mass spectrometric analysis was performed under
the following conditions. Sample inlet: sheath gas (nitro-
gen) 60 psi; auxiliar gas (nitrogen) 5 psi; capillary heater
210C. Sample inlet voltage setting: polarity both positive
and negative; ion spray voltage ±5 kV; capillary voltage
±19 V. Scan conditions: maximum ion time 200 ms; ion
time 5 ms; full microscan 3; scan range: 150–2000 m ⁄ z,
both positive and negative polarity. Duration of acquisi-
tion: 29 min (from minute 3 to minute 32 of the chro-
matographic analysis). Bioautographies of the HPLC
fractions were performed with test organisms in liquid
microtiter plate assay as described above.
Results
Growth features of Antarctic cyanobacteria
The growth of the 51 isolates was tested at three different
temperature ranges: 7–10, 20–22 and 28–30C. At 7–
10C, all the strains were able to grow, but at very low
rates. This temperature range was adopted for mainte-
nance. At 20–22C, 48 out of the 51 strains were able to
grow, and sufficient biomass for bioactivity assays could
be produced. Three did not grow, but remained alive. At
28–30C, most of the strains died.
Table 2 reports the description of the 51 cyanobacterial
strains for which laboratory mass cultivation was
Screening of Antarctic cyanobacteria N. Biondi et al.
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attempted. On the basis of the morphological character-
ization previously reported (Taton et al. 2006b), ca 80%
of the strains belong to the Oscillatoriales and ca 20% to
the Nostocales. Within the Nostocales, six strains were
assigned to the genus Nostoc and five to the genus Calo-
thrix. Oscillatorian strains were assigned to six morpho-
species, defined in agreement with Koma´rek and
Anagnostidis (2005). Three of them (Phormidium priest-
leyi, Leptolyngbya frigida, Leptolyngbya antarctica) were
considered as endemic to the Antarctica by Koma´rek
(1999). Sequencing of 16S rRNA gene led to the assign-
ment of the 51 strains to 17 OTUs previously described
(Taton et al. 2006b). As shown in Table 2, oscillatorian
species are grouped in 14 OTUs (from 16ST01 to
16ST14), which include six novel (at least 2Æ5% dissimi-
larity with the sequences deposited in databases) and
three exclusively Antarctic (sequences already found, but
only in Antarctic samples) OTUs. All Nostoc strains
belong to the 16ST16 OTU. Within the Calothrix genus,
two strains were assigned to different OTUs, of which
one was considered as novel. We were unable to obtain
the sequences of the three remaining isolates.
At 20–22C, 13 classes of biomass productivity of
10 mg l)1 d)1 range each were recognized. Most of the
strains (43 out of 48) attained a productivity lower than
60 mg l)1 d)1. Only one strain produced more than
120 mg l)1 d)1. The variability of productivity among the
batches was in general very high, with a coefficient of var-
iation ranging from 40% to 100% (see Table 2). There
was a certain relationship between productivity and OTU
assignment. All the most productive strains belonged to
the same oscillatorian OTU (16ST01New), whereas many
of the less productive strains, were grouped in the oscilla-
torian 16ST11Ant OTU. Two strains of the 16ST11Ant
OTU (ANT.LWA.1 and ANT.LWAV6.1) together with
the other endemic L. antarctica ANT.BFI.1 (16ST13Ant),
even if viable, did not grow in any of the conditions
tested at 20–22C.
One common feature which limited growth of many of
the less productive isolates was their inability to grow at
high irradiance (photosensitivity) (Table 2). At 40 lmol
photons m)2 s)1, 10 strains (eight Oscillatoriales belong-
ing to different OTUs and two Nostocales), showed
strong depigmentation followed by death and were con-
sidered photosensitive. When cultivated at 30 lmol pho-
tons m)2 s)1, their productivity was lower than 40 mg
l)1 d)1. Twenty-three strains (20 Oscillatoriales and three
Nostocales) showed some depigmentation and low pro-
ductivity at irradiances higher than 30 lmol photons
m)2 s)1 and were considered slightly photosensitive.
Fifteen strains (nine Oscillatoriales, one Nostoc and all the
five Calothrix isolates) were not photosensitive. Among
these, four strains of Pseudophormidium sp. belonging to
the 16ST01New OTU could be grown at 90 lmol photons
m)2 s)1 and reached the highest productivities (90–
130 mg l)1 d)1).
Another factor responsible for low productivity was
sensitivity to air bubbling (Table 2): 34 cyanobacteria
grew well with air bubbling, whereas the remaining 14
strains could be grown only with orbital shaking. These
air-bubbling sensitive strains were among the lower pro-
ducers (£10 mg l)1 d)1, in general). Among these, four
strains were assigned to L. frigida and belonged to
16ST07New, 16ST08New and 16ST09New OTUs, other four
to L. antarctica (16ST11Ant) and one to Pseudophormidi-
um sp. (16ST02). None of the Calothrix strains grew
when air-bubbled, but they reached productivities of 20–
30 mg l)1 d)1, when grown with orbital shaking. Other
factors that negatively influenced productivity were the
production of high amounts of polysaccharide, observed
in one Nostoc (16ST16) and in one Leptolyngbya cf. fragi-
lis (16ST02), and the formation of large aggregates, which
very likely reduce light availability to the cells, as in one
P. priestleyi (16ST03New) and in all the strains belonging
to Phormidium murrayi (16ST14) and Calothrix sp.
(Table 2).
Phormidium priestleyi strain ANT.L52.6 (16ST03New)
selected, as reported below, on account of its potent anti-
fungal activity, was cultivated for 88 days in a 10-l photo-
bioreactor in a semi-continuous harvesting regimen and
at an average concentration of 1Æ2 g l)1. The maximum
growth rate and productivity were 0Æ14 d)1, correspond-
ing to a generation time of 5 days, and about 95 mg
l)1 d)1. After 3 months, contamination by a green alga
was observed and thus the whole culture was harvested.
Over the whole cultivation period more than 43 g of
biomass (dry weight) were produced.
Bioactivities of Antarctic cyanobacteria
In all, 126 samples, prepared from 48 cyanobacterial
strains, grown as described above, were assayed against a
panel of human pathogens and for cytotoxicity. Except in
cases of very low productivity, on average, three extrac-
tion methods, two using the biomass and one using the
thawing water (see Materials and Methods and Table 1),
were applied to each strain to favour the recovery of
active metabolites with different molecular weights and
lipo ⁄hydrophilic properties ⁄polarities. Ethyl acetate was
found to be the most appropriate solvent to extract
bioactivity from these biomasses (Table 2). For all the
strains, except ANT.L52.6, only one type of extract
resulted active, whereas half of the cytotoxic strains
showed toxicity in more than one type of extract.
Of the 48 strains tested, 17 (35%) were active. Among
them seven showed only antibacterial activity, three only
N. Biondi et al. Screening of Antarctic cyanobacteria
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antifungal activity and seven both antibacterial and anti-
fungal activity (Table 2). No activity was detected vs the
Gram-negative E. coli and the yeast C. albicans (data not
shown), whereas the frequency of activity against the
Gram-positive Staph. aureus was 29%. The growth of A.
fumigatus and C. neoformans was inhibited by 4% and
20% of the tested strains, respectively. When tested in an
in vitro assay, previously developed for the rapid identifi-
cation of extracts active on cancer mammalian cells
(Marinelli et al. 2004), half of the isolates were found to
be cytotoxic (Table 2). The highest frequency of antimi-
crobial activity was detected in Pseudophormidium sp.
(16ST01New) and P. priestleyi (16ST03New) that belong to
novel OTUs, as well as in Nostoc sp. (16ST16). None of
the strains assigned to Leptolyngbya cf. fragilis (16ST02),
L. frigida (16ST07New, 16ST08New, 16ST09New and
16ST10) and Calotrhix sp. morphospecies appeared to be
microbiologically active. Among the eight L. antarctica
isolates (16ST11Ant, 16ST12), three strains showed anti-
bacterial activity. Four strains belonging to P. priestleyi or
P. murrayi were slightly active vs Staph. aureus, whereas
two (ANT.L52.4 and ANT.L52.6) out of the three P.
priestleyi assigned to the 16ST03New OTU showed potent
antifungal activity (Table 2).
The distribution of cytotoxicity did not correlate with
the pattern of antimicrobial activities.
Eight out of the 17 microbiologically inactive strains of
Leptolyngbya cf. fragilis, L. frigida and Calotrhix sp. were
cytotoxic. Among L. antarctica, only one of the three
strains endowed with antibacterial activity and two
microbiologically inactive isolates produced toxins. On
the other hand, most of the microbiologically active
Pseudophormidium sp. (16ST01New), P. priestleyi
(16ST03New, 16ST04) and Nostoc sp. (16ST16) were also
cytotoxic. As the crude extracts contain a variety of differ-
ent components, at this level of screening it was not pos-
sible to establish if the same or different metabolites were
responsible for the cytotoxic and antibacterial ⁄ antifungal
activities. Thus, preliminary analytical studies were per-
formed with a subset of the strains (hits) that exhibited
relatively potent antibacterial and ⁄or antifungal activities.
The fractions active against A. fumigatus from the
strains P. priestleyi ANT.L52.4 and ANT.L52.6
(16ST03New) showed very similar chromatographic pro-
files and eluted with the same retention time (from 18 to
19 min), whereas the cytotoxic fraction (present only in
ANT.L52.6) was clearly separated and eluted with a reten-
tion time of 26 min. Table 3 shows the antifungal and
cytotoxic activities of the different fractions from strain
ANT.L52.6, measured as endpoints in the microdilution
method (Gaspari et al. 2005). In the same liquid chroma-
tography ⁄mass spectrometry system, Pseudophormidium
sp. ANT.LPR.2 (16ST01New), L. antarctica ANT.LG2.3
(16ST11Ant) and Nostoc sp. L34.1 (16ST16) showed that
the fractions active against Staph. aureus eluted with simi-
lar retention times, suggesting that the three strains
produced chemically similar antibacterial compounds.
Cytotoxicity was associated with a peak eluting later on
in the chromatogram, which was present both in Pseudo-
phormidium sp. ANT.LPR.2 and L. antarctica ANT.LG2.3,
but not in Nostoc sp. ANT.L34.1 (data not shown). When
the mass spectra obtained from the peaks corresponding
to the antifungal, antibacterial and cytotoxic activities
from the selected hits so far investigated were compared
with those related to active microbial products stored
either in the Vicuron proprietary database on microbial
products (Lazzarini et al. 2001) or in the commercially
available Dictionary of Natural Products (Anonymous
2003), no known antimicrobial metabolite was identified,
suggesting a chemical novelty at the basis of the activity
of these Antarctic cyanobacteria, which needs to be fur-
ther investigated.
Discussion
Several studies have focused on cyanobacterial diversity in
microbial mats of Antarctic lakes. Nevertheless, the num-
ber of Antarctic cyanobacterial strains available in culture
is limited and little is known concerning their optimum
cultivation conditions, physiology and metabolic diversity.
Following our recent effort to obtain a wide variety of cy-
anobacterial strains from this biota and characterize them
at the morphological and molecular level (Taton et al.
2006b), this study aimed to a first evaluation of their
potential as a novel source of pharmaceutically valuable
compounds. An essential requirement to this end was the
development of cultivation and screening techniques,
Table 3 Activity of the raw methanolic extract of the biomass from
the strain Phormidium priestleyi ANT.L52.6 cultivated in a 10-l photo-







Raw extract 1 : 256 1 : 40
1–17 <1 : 4 no
18 1 : 4 no
19 1 : 4 no
20–25 <1 : 4 no
26 <1 : 4 1 : 20
27–32 <1 : 4 no
*Antifungal activity is measured as an endpoint in microdilution the
method, i.e. the highest dilution which inhibits 80% of test strain
growth.
Cytotoxicity is measured as endpoint in microdilution method, i.e.
the highest dilution which inhibits 40% of HeLa cell thymidine
uptake.
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which allowed the identification of strains producing
interesting bioactivities (hits), and the supply of sufficient
material for the biological and chemical characterization
of the active metabolites. In this work, we found that
most of the cyanobacteria isolated from microbial mats in
a variety of Antarctic lakes (Taton et al. 2006b) grew
better around 20C than at lower or higher temperatures,
confirming the usual psychrotolerant – not psychrophilic
– nature of Antarctic cyanobacterial communities (Sea-
burg et al. 1981; Tang et al. 1997; Tang and Vincent
1999). Despite the mesophilic nature of these organisms,
that allowed to grow them at relatively high temperatures,
productivity was generally very low (£60 mg l)1 d)1) with
growth rates (l) in the range of 0Æ02–0Æ44 d)1, values
similar to those reported for other polar cyanobacteria
(Roos and Vincent 1988; Tang et al. 1997; Tang and Vin-
cent 1999). Photosensitivity partially explained the low
productivity and low growth rate of many strains. In par-
ticular, this was the case for strains isolated from benthic
lacustrine mats under a 8–12 month ice layer and thus
probably adapted to low irradiances (Hodgson et al.
2004). On the contrary, almost all the strains that were
not photosensitive were isolated from lakes with a maxi-
mum depth of less than 1 m (Taton et al. 2003, 2006a),
and hence they were presumably adapted to high irradi-
ances. Other factors limiting productivity depended on
the mode of cyanobacterial growth in mass culture, e.g.
formation of large aggregates, sensitivity to air bubbling,
and production of high amounts of polysaccharide. The
high variability of productivity observed among replicated
cultures of the same strain evidenced a general high sensi-
tivity of these isolates to small variations in the culture
conditions, especially for the polysaccharide-producing
strains. This variability can be partly explained with the
short time elapsed from strain isolation to cultivation,
that could have not allowed the ‘selection’ of the cell
population better adapted to the laboratory conditions.
For these reasons, a clear-cut correlation of growth fea-
tures with morphological and 16S rRNA OTU grouping
was not always traceable. Acclimation to light-limited
culture conditions and cultivation under relatively high
irradiances in photobioreactors of higher volume under
careful control of temperature, irradiance, pH and med-
ium composition are the sequence of steps needed for the
exploitation of selected strains (hits) (Tredici 2004). For
this, one of these hits, P. priestleyi ANT.L52.6, was culti-
vated for 88 days in a 10-l photobioreactor, allowing the
production of more than 40 g of biomass dry weight,
necessary for the further bioactivity characterization. The
maximum growth rate achieved was similar to that
obtained in the smaller reactors, but a higher maximum
productivity was achieved (95 mg l)1 d)1 vs 48 mg
l)1 d)1). However, in a scaling-up perspective, the low
irradiance required by this organism and its low growth
rate that makes it a bad competitor against contaminants,
might severely limit the outdoor cultivation and exploita-
tion of this strain.
In this work, for screening purposes, extraction meth-
ods were devised to process differing amounts of biomass
produced and this allowed a first insight into the meta-
bolic diversity of a relatively large number of cyano-
bacterial isolates from Antarctica. Many of them were
Oscillatoriales and Nostocales belonging to novel or
endemic Antarctic taxa, or showed phylogenetic relation-
ships with other polar cyanobacteria (Taton et al. 2006b).
Burja et al. (2001) reported that 15 Oscillatoriales and 41
Nostocales produced 197 and 126 different bioactive
metabolites, respectively. These two subsections thus
appear as the most metabolically versatile within the
cyanobacteria. The widely represented chemical classes
were lipopeptides, depsipeptides, macrolides, macrocycles,
indoles and alkaloids. In the course of our screening, the
majority of the microbiologically active strains inhibited
a Gram-positive pathogen, whereas no activities were
found against Gram-negative and yeast representatives.
This is in agreement with the few data available in the
literature about antimicrobial activity frequency in cyano-
bacteria screenings (Kreitlow et al. 1999). Cytotoxicity
was common among the cyanobacteria investigated in
this work. As previously reported (Namikoshi and Rine-
hart 1996; Burja et al. 2001), cyanobacteria constitute a
major source of toxins. Alkaloid neurotoxins and the
cyclic peptide hepatotoxins are often produced by cyano-
bacterial water blooms worldwide. Recently some cyto-
toxins have been evaluated as anticancer compounds
(Liang et al. 2005). The pattern of antimicrobial and
cytotoxic activities from our cyanobacterial isolates were
not in accordance with the phylogenetic relationships,
but rather specific to certain strains. This confirms our
previous findings that strains with identical 16S rRNA
sequences isolated either from the same lake or from dif-
ferent lakes may produce different patterns of bioactivity,
or that strains belonging to different morphospecies and
OTUs may produce the same active metabolite (Taton
et al. 2006b). For example, in this work, only two out of
the three P. priestleyi strains belonging to the 16ST03New
OTU inhibited A. fumigatus growth. The two active
strains were isolated from the same lake and exhibited
identical partial 16S rRNA gene sequences (Taton et al.
2006a,b), but only one was cytotoxic. On the contrary, a
similar antibacterial activity was identified in three differ-
ent morphospecies, Pseudophormidium sp., L. antarctica,
and Nostoc sp.
The chemical diversity of the active fractions, as evi-
denced by the mass spectra, of the isolated Antarctic
strains shows the potential of this microbial group and
N. Biondi et al. Screening of Antarctic cyanobacteria
ª 2008 The Authors
Journal compilation ª 2008 The Society for Applied Microbiology, Journal of Applied Microbiology 9
confirms the utility of isolating novel strains from pecu-
liar geographical locations before screening for bioactive
compounds.
Acknowledgements
This work was supported by the European Community
(MICROMAT Project BIO4-98-0040). Thanks for the
field samplings are due to Kathy Welsh (USA-McMurdo
Dry Valleys Long Term Ecosystem Research Program pro-
ject), Pip Noon (British Antarctic Survey, UK), Johanna
Laybourn-Parry, Gareth Murtagh, Paul Dyer, Ingmar
Janse, Tracey Henshaw, Wendy Quayle (University of
Nottingham, UK with logistic support from the Austra-
lian Antarctic Division).
References
Anonymous (2003) Dictionary of Natural Product on CD-
ROM, Version 12:1. London: Chapman & Hall ⁄CRC Press
UK.
Biondi, N., Piccardi, R., Margheri, M.C., Rodolfi, L., Smith,
G.D. and Tredici, M.R. (2004) Evaluation of Nostoc strain
ATCC 53789 as a potential source of natural pesticides.
Appl Environ Microbiol 70, 3313–3320.
Brambilla, E., Hippe, H., Hagelstein, A., Tindall, B.J. and
Stackebrandt, E. (2001) 16S rDNA diversity of cultured
and uncultured prokaryotes of a mat sample from Lake
Fryxell, McMurdo Dry Valleys, Antarctica. Extremophiles 5,
23–33.
Burja, A.M., Banaigs, B., Abou-Mansour, E., Burgess, J.C. and
Wright, P.C. (2001) Marine cyanobacteria – a prolific
source of natural products. Tetrahedron 57, 9347–9377.
Burja, A.M., Dhamwichukorn, S. and Wright, P.C. (2003)
Cyanobacterial postgenomic research and systems biology.
Trends Biotechnol 21, 504–511.
Gaspari, F., Paitan, Y., Mainini, M., Losi, D., Ron, E.Z. and
Marinelli, F. (2005) Myxobacteria isolated in Israel as
potential source of new anti-infectives. J Appl Microbiol 98,
429–439.
Hodgson, D.A., Vyverman, W., Verleyen, E., Sabbe, K., Leavitt,
P.R., Taton, A., Squier, A.H. and Keely, B.J. (2004) Envi-
ronmental factors influencing the pigment composition of
in situ benthic microbial communities in east Antarctic
lakes. Aquatic Microb Ecol 37, 247–263.
Koma´rek, J. (1999) Diversity of cyanoprokaryotes (cyanobacte-
ria) of King George Island, maritime Antarctica – a survey.
Arch Hydrobiol 94, 181–193.
Koma´rek, J. and Anagnostidis, K. (2005) Cyanoprokaryota 2.
Teil Oscillatoriales. Heidelberg: Elsevier GmbH, Spektrum
Akademischer Verlag.
Kreitlow, S., Mund, S. and Lindequist, U. (1999) Cyanobacte-
ria – a potential source of new biologically active sub-
stances. J Biotechnol 70, 61–63.
Lazzarini, A., Cavaletti, L., Toppo, G. and Marinelli, F. (2001)
Rare genera of actinomycetes as potential producers of
new antibiotics. Antonie Van Leeuwenhoek 79, 399–405.
Liang, J., Moore, R.E., Moher, E.D., Munroe, J.E., Al-Awar,
R.S., Hay, D.A., Varie, D.L., Zhang, T.Y. et al. (2005)
Cryptophycins-309, 249 and other cryptophycin analogs:
preclinical efficacy studies with mouse and human tumors.
Invest New Drugs 23, 213–224.
Marinelli, F., Brunati, M., Sponga, F., Ciciliato, I., Losi, D.,
Van Trappen, S., Go¨ttlich, E., de Hoog, S. et al. (2004)
Biotechnological exploitation of heterotrophic bacteria and
filamentous fungi isolated from benthic mats of Antarctic
lakes. In Microbial Genetic Resources and Biodiscovery ed.
Kurtbo¨ke, I. and Swings, J. pp. 163–184. Queensland:
Queensland Complete Printing Services.
Namikoshi, M. and Rinehart, K.L. (1996) Bioactive com-
pounds produced by cyanobacteria. J Indust Microbiol 17,
373–384.
Rippka, R., Deruelles, J., Waterbury, J.B., Herdman, M. and
Stanier, R.Y. (1979) Generic assignment, strains histories
and properties of pure cultures of cyanobacteria. J Gen
Microbiol 111, 1–61.
Roos, J.C. and Vincent, W.F. (1988) Temperature dependence
of UV radiation effects on Antarctic cyanobacteria. J Phy-
col 34, 118–125.
Seaburg, K.G., Parker, B.C., Wharton, S.A.J. and Simmons,
G.M.J. (1981) Temperature-growth responses of algal iso-
lates from Antarctic oases. J Phycol 17, 353–360.
Stackebrandt, E. and Goebel, B.M. (1994) Taxonomic note: a
place for DNA-DNA reassociation and 16S rRNA sequence
analysis in the present species definition in bacteriology.
Int J Syst Bacteriol 44, 846–849.
Tang, E.P.Y. and Vincent, W.F. (1999) Strategies of thermal
adaptation by high-latitude cyanobacteria. New Phytol 142,
315–323.
Tang, E.P.Y., Tremblay, R. and Vincent, W.F. (1997) Cyano-
bacterial dominance of polar freshwater ecosystems: are
high-latitude mat-formers adapted to low temperature?
J Phycol 33, 171–181.
Taton, A., Grubisic, S., Brambilla, E., De Wit, R. and Wil-
motte, A. (2003) Cyanobacterial diversity in natural and
artificial microbial mats of Lake Fryxell (McMurdo Dry
Valleys, Antarctica): a morphological and molecular
approach. Appl Environ Microbiol 69, 5157–5169.
Taton, A., Grubisic, S., Balthasart, P., Hodgson, D.A., Laybo-
urn-Parry, J. and Wilmotte, A. (2006a) Biogeographical
distribution and ecological ranges of benthic cyanobacteria
in East Antarctic lakes. FEMS Microbiol Ecol 57, 272–289.
Taton, A., Grubisic, S., Ertz, D., Hodgson, D.A., Piccardi, R.,
Biondi, N., Tredici, M.R., Mainini, M. et al. (2006b) Poly-
phasic study of Antarctic cyanobacterial strains. J Phycol
42, 1257–1270.
Tindall, B.J. (2004) Prokaryotic diversity in the Antarctic: the
tip of the iceberg. Microb Ecol 47, 271–283.
Screening of Antarctic cyanobacteria N. Biondi et al.
10 Journal compilation ª 2008 The Society for Applied Microbiology, Journal of Applied Microbiology
ª 2008 The Authors
Tindall, B.J., Brambilla, E., Steffen, M., Neumann, R., Pukall,
R., Kroppenstedt, R.M. and Stackebrandt, E. (2000) Culti-
vatable microbial biodiversity: gnawing at the Gordian
knot. Environ Microbiol 2, 310–318.
Tredici, M.R. (2004) Mass production of microalgae:
photobioreactors. In Handbook of Microalgal Cultures
ed. Richmond, A. pp. 178–214. Oxford: Blackwell
Publishing.
Van Trappen, S., Mergaert, J., Van Eygen, S., Dawyndt, P.,
Cnockaert, M.C. and Swings, J. (2002) Diversity of 746
heterotrophic bacteria isolated from microbial
mats from ten Antarctic lakes. Syst Appl Microbiol 25, 603–
610.
Waterbury, J.B. and Stanier, R.Y. (1981) Isolation and growth
of cyanobacteria from marine and hypersaline environ-
ments. In The Prokaryotes: A Handbook on Habitats, Isola-
tion, and Identification of Bacteria ed. Starr, M.P., Stolp,
H., Truper, H.G., Balows, A. and Schlegel, H.G. pp. 221–
223. Berlin: Springer-Verlag.
Wiegand, C. and Pflugmacher, S. (2005) Ecotoxicological
effects of selected cyanobacterial secondary metabolites, a
short review. Toxicol Appl Pharmacol 203, 201–218.
N. Biondi et al. Screening of Antarctic cyanobacteria
ª 2008 The Authors
Journal compilation ª 2008 The Society for Applied Microbiology, Journal of Applied Microbiology 11
